This report in Cancer Decisions describes a recent study published in Radiotherapy and Oncology and recalls earlier ones published in the Journal of Clinical Oncology and the Lancet that demonstrate outstanding benefits for bladder, cervical and rectal cancer. Hyperthermia is the warming of tissue to enhance localized immune and circulatory vigor. It is now part of standard treatment for cervical cancer in Holland and recommended by the German Cancer Society. Dr. Ralph Moss concludes in this report: “In my opinion, a great many American patients will die needlessly before the cancer establishment wakes up to the fact that hyperthermia is a relatively harmless way of prolonging the lives of many cancer patients.”

-

The National Cancer Institute is giving lip service to “personalized oncology”, while tumor cell culture chemosensitivity testing for optimizing chemotherapy has languished in a backwater. See this brief report by Dr. Ralph Moss of Cancer Decisions.

-